Quantcast
Last updated on April 21, 2014 at 12:45 EDT

Latest Claret Medical Inc. Stories

2014-02-18 08:30:25

SENTINEL trial to evaluate the Safety and Efficacy of the Sentinel CPS in TAVR population SANTA ROSA, Calif., Feb. 18, 2014 /PRNewswire/ -- Claret Medical, Inc., a developer of innovative solutions for cerebral protection during structural heart interventions, vascular interventions, and cardiac surgery procedures, announced that it has received Investigational Device Exemption (IDE) approval from the FDA for a multicenter study of the Company's Sentinel Cerebral Protection System...

2014-01-27 08:27:21

Latest Generation Device in Embolic Capture and Removal for Reducing Stroke during TAVR Procedures SANTA ROSA, Calif., Jan. 27, 2014 /PRNewswire/ -- Claret Medical, Inc., a developer of innovative solutions for cerebral protection during structural heart interventions, vascular interventions, and cardiac surgery procedures, announced that it has received CE Mark for the Sentinel(TM) Cerebral Protection System (CPS) for embolic protection during Transcatheter Aortic Valve Replacement...

2013-12-02 08:30:42

SENTINEL study to evaluate the Sentinel Cerebral Protection System in TAVR population SANTA ROSA, Calif., Dec. 2, 2013 /PRNewswire/ -- Claret Medical, Inc., a developer of innovative solutions for cerebral protection during structural heart interventions, vascular interventions, and cardiac surgery procedures, announced that it has submitted an investigational device exemption (IDE) application to the US Food and Drug Administration for a multicenter study of the Company's Sentinel...

2013-05-20 00:21:40

The Montage 2 Dual Filter System is the only approved device to protect the carotid arteries by capturing embolic debris during TAVR. SANTA ROSA, Calif., May 20, 2013 /PRNewswire/ -- Claret Medical, Inc. announced the publication of an original manuscript by Dr. Nicolas Van Mieghem et al., Histopathology of Embolic Debris Captured During Transcatheter Aortic Valve Replacement. Published ahead of print in Circulation, May 7(th) this research is the result of a collaboration between...

2013-02-27 08:28:23

The Montage 2(TM) is the only approved filter system protecting the carotid arteries capturing embolic debris during intravascular procedures such as Transcatheter Aortic Valve Repair (TAVR). SANTA ROSA, Calif., Feb. 27, 2013 /PRNewswire/ -- Claret Medical, Inc. announced today that its 2nd generation filtration system, Montage 2 Dual Filter System received CE Mark approval with an innovative catheter handle furthering the simplicity and ease of use of the technology while providing...

2011-10-31 13:08:00

SANTA ROSA, Calif., Oct. 31, 2011 /PRNewswire/ -- Claret Medical, Inc. announced today that its Montage System has received CE Mark approval as the world's first complete system of filtration to protect both carotid arteries simultaneously. The 6F catheter is delivered via radial or brachial access, providing complete neuro protection during intravascular procedures such as Transcatheter Aortic Valve Intervention (TAVI). The unique design of the Montage System provides for not only...